Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.2, Iss.2, 2003-03, pp. : 161-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective serotonin re-uptake inhibitors and the risk of bleeding

By Weinrieb Robert M Auriacombe Marc Lynch Kevin G Lewis James D

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitors in anorexia nervosa

By Vaswani Meera Kalra Harish

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 349-357

Informa Healthcare

Access to resources Recommend Favorite

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

By Alwan Sura Friedman Jan M.

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 493-509

Adis International

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

By Silver Henry

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2053-2058

Informa Healthcare

Access to resources Recommend Favorite

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

By Dell’Osso Bernardo Allen Andrea Hollander Eric

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2727-2740

Informa Healthcare

Access to resources Recommend Favorite